| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594438 | American Heart Journal | 2017 | 24 Pages |
Abstract
Poor cell-mediated immune function measured by a clinically available assay could be associated with more adverse long-term prognosis in patients with advanced heart failure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Vijaiganesh MD, MRCP, Adrian V. MD, PhD, Clay A. MD, MPH, Randall C. MD, MPH, W. H. Wilson MD,